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Many immunologic cells require exposure to antigen to display detectable levels of 
specific  function.  One  cell  type  requires  no  known  previous  exposure  to  antigen; 
however,  it  displays  a  specificity  for  particular  target  cells  (1-5).  These  ceils  lyse 
certain  neoplastic  or normal cells without  deliberate  immunization  and  have thus 
been termed natural killer (NK) 1 cells. Because these cells in the mouse comprise <5% 
of spleen  cells,  they have been defined  according to their expression of cell surface 
antigens  and  their  ability  to  lyse  certain  tumor  target  cells.  NK  cell  activity  is 
eliminated  by complement-dependent  lysis  with  anti-Ly-5,  anti-NK-1,  anti-Qat-4, 
and  anti-Qat-5,  and  is  resistant  to  anti-Lyt  antisera  (5-7).  Activity  can  also  be 
eliminated  after multiple  treatment  with  anti-Thy-1  antisera and  complement  (8). 
Two patterns of NK reactivity have been found in mouse spleen cells. In both cases, 
spleen  cells  lyse virus-infected  tumor targets such  as  the  YAC-1,  RLd,  MBL-2,  or 
RBL-5 lymphomas. After activation with bacille Calmette-Gu~rin (9), interferon (IF) 
inducers  (10-12), certain tumors (13), or undefined factors (14,  15),  NK cells acquire 
the ability to lyse additional tumors such as the EL4 lymphoma or P815 mastocytoma, 
which are relatively resistant to nonactivated NK cells. 
The  relation  of NK cells  to  the  cells  that  mediate  antibody-dependent  cellular 
cytotoxicity is unclear. Although some data support the hypothesis that NK cells can 
mediate  both  kinds  of activities  (16,  17),  it  has  not  been  possible  to  settle  these 
questions because homogeneous populations of NK cells have been difficult to isolate. 
Just  as  myelomas have  facilitated  the  analysis  of B  cells  and  immunoglobulin, 
cloned  populations  of cells showing  NK activity can better define the cellular and 
molecular basis of the activities described  above.  Several continuous  cell lines have 
been described recently that lyse the YAC-1  lymphoma (18,  19).  We have cloned a 
cell population from Ig-Ly-5  + spleen cells that lyses the YAC-1 lymphoma 100 times 
more efficiently than NK-containing spleen populations. Unlike other lines described 
previously,  these  cells  also  iyse  the  EL4  lymphoma  and  P815  mastocytoma,  and 
mediate  another  specialized  function:  antibody-dependent  cellular  cytoxicity 
(ADCC). 
* Supported by grants CA-26695, AI-12184, and AI-13600 from the National Institutes of Health, 
Bethesda, Md. 
1 Abbreviations used in this paper: ADCC, antibody-dependent cellular cytotoxicity; CE, clonal efficiency; 
CCM, complete conditioned medium; CM, conditioned medium; CTL, cytntoxic T lymphocytes; FCS, 
fetal calf serum; IF, interferon; LPS, lipopolysaccharide;  mc, monoclonal; NK, natural killer; PAS, periodic 
acid-Schiff  peroxidase; SRBC, sheep erythrocytes. 
1582  J. ExP. MEn. © The Rockefeller  University Press • 0022-1007/81/06/1582/10 $1.00 
Volume 153  June 1981  !.582-1591 NABEL, BUCALO, ALLARD, WIGZELL, AND CANTOR  1583 
Materials and Methods 
Animals.  All T cells for cloning were obtained from C57BL/6 mice. Cells from C57BL/6 or 
BALB/c  mice  (obtained from The Jackson  Laboratory, Bar  Harbor,  Maine) were  used  to 
produce conditioned medium (CM; see below). 
Antisera.  Lyt-l.2 and Lyt-2.2 antisera, prepared as described (20), were kindly donated by 
Dr. F. W. Shen; NK-1 antisera by Dr. G. Koo; monoclonal (mc) anti-Thy-l.2 by Dr. Ed Clark; 
mc-anti-Lyt-1 and mc-anti-Lyt-2 by Drs. J. Ledbetter and L. Herzenberg; and mc-anti-Qat-5 
by Dr. U. Hammerling. Expression of Ly- 1 and Ly-2 by each clone was determined with both 
Lyt alloantisera and mc Lyt antibodies by immunofluorescence. 
Cell Culture and Cloning.  Culture conditions for initiation and maintenance ofcell lines have 
been described (21). Briefly, cells were diluted into microwells (3040; Falcon Labware, Div. of 
Becton, Dickinson & Co., Oxnard, Calif.) at estimated final concentrations of 100, 10,  I, and 
<1  cells/well. Each well contained 0.1  ml of complete conditioned medium (CCM; 21), and 
irradiated (1,500  rad)  cell  monolayers from different tissues  (final concentrations 4-8 ×  10  ~ 
cells/well). Cultures were supplemented every 2 d with 30 #1 CCM until colonies were visible 
(10 d-3 wk) in wells that initially received <100 cells. Cloning efficiency (CE) was calculated 
by Poisson distribution (22). At least 96 wells were used to calculate each CE. The fraction of 
negative wells  was plotted as a  function of the logarithm of initial cell  number. Single cells 
from colonies arising at frequencies <36% with CE >5% were regrown twice after single cell 
micromanipulation.  With some exceptions, the characteristics of these initial cell colonies were 
stable and identical to those of cloned populations derived from them by single cell micro- 
manipulation. Separate tests of more than 12 different cell colonies showed that 3-10 daughter 
clones derived from each expressed  the cell surface antigens, morphology, and function of the 
parent colony. After the initial cloning procedure, cells were expanded in cultures containing 
CM in the absence of irradiated cell monolayers (21). Doublin,~ times ranged from 24 to 48 h 
for all cells  tested.  Cells could be expanded to numbers >10.  At least  20  different cloned 
populations have been propagated for 8 mo in vitro. 
Frozen  Cells for Storage.  Cloned cells were frozen in liquid N2 and thawed with complete 
recovery of growth and function, by the use of a modification (21) of the method of Lionetti 
and colleagues (23). 
Positive Selection  of Ly-5 + Cells.  Cells were prepared according to a  previous method  (7). 
Briefly, spleen cells from B6 mice were passed through a nylon-wool column and treated with 
anti-Thy-1.2 (final dilution 1:20) and a selected rabbit serum as a source of complement. These 
cells were washed three times and incubated for 30 min at 4°C with anti-Ly-5.1 (final dilution 
of 1:20) in the absence of complement. 5 ml of these ceils (107/m[)  were added to petri dishes 
(100 × 20 ram, Falcon 3003) coated with a monolayer of sheep erythrocytes (SRBC) conjugated 
to protein A. Coupling of SRBC to protein A was performed by the method of Parrish and 
Hayward  (24);  protein A-SRBC monolayers were prepared by the method of Stuhing and 
Burke (25). 
After  a  15-min incubation of lymphocytes at  4°C,  the  plates  were  gently swirled  and 
incubated an additional 15 min at 4°C. Unbound (nonadherent) cells were removed by gently 
aspirating the supernatant with a Pasteur pipette. Bound cells were released from the mono- 
layers after the addition of 2 ml of distilled water for 15 s, followed by two additions of 2 ml of 
phosphate-buffered saline. This procedure  lyses  SRBC  and permits recovery of the  bound 
lymphocyte population. The recovered cell population (unbound plus bound) represents _-->80 
of the starting (input) cell population. 
NK Assay.  Lysis of the YAC-1 lymphoma, an NK-sensitive tumor (2, 26; >35% specific lysis 
at an effector:target ratio of 1:1) and lack of lysis against the radiation-induced  C57BL RL-12 
lymphoma, an NK-resistant tumor, was used to  define NK activity. Briefly,  2  ×  104 ~Cr- 
labeled target  cells  (YAC-1,  RL-12,  EL-4,  or  P815)  were  incubated in minimum essential 
medium plus 10% fetal calf serum (FCS) alone or with various cloned cells for 3.5 h at 37°C in 
a humidified atmosphere with 5% CO2 (5). The amount of gamma radioactivity released from 
triplicate cultures was measured. Cytoxicity is expressed  as percent specific  lysis according to 
the formula: 
experimental release-spontaneous release  100. 
Percent lysis =  maximal release  (HC1)-spontaneous release × 1584  LYMPHOCYTE  CLONES 
Preparation ofLipopolysaccharide (LPS)-activated  B Cells.  To obtain purified B cells, spleen cells 
were suspended  in anti-Lyt-1.2 plus anti-Lyt-2.2 plus mc-anti-Thy-1.2 at optimal lytic concen- 
trations  for 30  min  at  room temperature,  washed,  and  incubated  in a  selected rabbit  serum 
(complement)  at  37°C  for  40  rain.  To  ensure  depletion  of all  T  cells,  this  treatment  was 
followed by  further  incubation  of the  remaining  cells with  mc-anti-Thy-l.2  (final  dilution, 
1:1,000)  and  rabbit  complement  at  37°C  for 30  min.  These  remaining  cells did  not  secrete 
appreciable Ig after 4 d  of culture in vitro unless purified T  cells were added. 
These cells were incubated with 20 ~g/ml Escherichia coil 055:B5 LPS (Sigma Chemical Co., 
St.  Louis,  Mo.)  at  37°C  in  a  humified  atmosphere  with  10%  COz  in  modified  Dulbecco's 
modified minimum essential medium, 4% FCS, 5  ×  10 -5 M  2-mecaptoethanol  and glutamine 
(2 mM). Cells (2 ×  106/ml)  were incubated  for 72 h  before radiolabeling with ~lCr for use in 
the cytotoxic assay. 
Results 
Isolation and Cloning of NK Cells.  Ly-5  + cells were enriched  ~12-fold  from spleen 
cell  populations  of B6  mice  (7)  before  cells  were  distributed  into  microwells  for 
cloning.  The frequency of functionally active NK colonies arising from this starting 
population was 27% compared with a frequency of 1% arising from unselected spleen 
cell populations.  12 clones expressed  the Thy-l+Lyt -1-2-Ly-5+Qat4+5 + cell surface 
components.  One  clone,  containing  cells expressing  this  surface phenotype  (C1.Ly- 
1-2-NK-1 +/11), was examined in detail. Subsequent analysis showed that it expressed 
the NK- 1 antigen, too. Lytic activity of these cells against the YAC- 1 lymphoma was 
100-fold more potent than  NK cells in spleen populations  (Table I; Fig.  1). 
Histochemistry.  Wright-Giemsa  (27) periodic-acid-Schiff (PAS) peroxidase (28) and 
nonspecific  esterase  (29)  reactions  were performed  by described  protocols  (Fig.  2). 
C1.Ly-1-2-NK-1+/11  did not contain peroxidase, nonspecific esterase, or PAS-positive 
TABLE  I 
Comparison of Functional CE of NK Cells after Positive Selection 
NK activ-  CE of NK 
Source of cells for cloning  CE  ity (%  cells 
positive) 
% 
A.  Normal mouse serum plus rabbit complement spleen  4.5  26.7  1.2 
B.  Ig-Thy-l-Ly-5  ÷ spleen cells  67  40  26.8 
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FI~3.  1.  Cell-mediated cytotoxicity against  the  YAC-1  lymphoma.  Uncloned  spleen  cells  (O), 
C1.Ly-I-2-NK-I+/11  (0)  and CI.Ly-I-2-NK-1-/1  (m)  were incubated with radiolabeled YAC-I 
lymphoma. No cells lysed the NK-resistant RL-12 leukemia. NABEL,  BUCALO,  ALLARD, WIGZELL, AND CANTOR  1585 
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Fro.  3.  Cellular targets ofCI.Ly-I-2-NK-I+/11.  CI.Ly-I-2-NK-I+/I  1 was incubated with radio- 
labeled cells from (A) normal tissue or (B) malignant cells for 3.5 h (see Materials and Methods). 
material  as  determined  by  conventional  histochemistry.  Acid  phosphatases  were 
detected in lysosomal granules. 
Cellular Targets of CI.Ly-1-2-NK-I+/11.  C1.Ly-I-2-NK-I+/11  was tested for lytic 
activity against several different target cells. YAC-1 and MBL2  lymphoma cells were 
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Fxe.  4.  Sensitivity to treatment with anti-Thy-1 and anti-Ly-5 plus complement. CI.Ly-I-2-NK- 
1+/1 l  cells  were  incubated  with  the  indicated  antisera  or  monoclonal  antibodies,  followed  by 
complement. This treatment was repeated, and lysis of YAC- 1 lymphoma was measured. Incubations 
with antisera alone did not reduce lytic activity. 
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Fro.  5.  ADCC to RL- 12 leukemia. CI.Ly- 1-2-NK- 1  +/11 was incubated with radiolabeled RL- 12 
mouse  leukemia  cells  that  had  been  incubated  previously  with  rabbit  anti-mouse lymphocyte 
antibody (X), rabbit anti-human lymphocyte antibody (O), or no antibody ((3). Addition of either 
IgG fraction in the absence of cloned cells causes no lysis of RL-12 leukemia cells. 
sensitive to "activated" NK cells  (1,  13,  14),  were also lysed. We also tested C1.Ly- 
1-2-NK-I+/11  for lytic activity against  normal syngeneic target cells derived from 
various tissues. Syngeneic LPS-activated B lymphocytes were very sensitive to lysis in 
contrast to concanavalin A-activated T  lymphocytes, thymocytes, and bone marrow 
cells (Fig. 3).  NK-resistant tumors RL-12 or L692 were resistant to lysis,  as was the 
K562 erythroleukemia, a  human NK target cell. Lytic activity was eliminated after 
two treatments of CI.Ly-I-2-NK-I+/11 with anti-Ly-5 and anti-Thy-1 plus comple- 
ment (Fig. 4). 
CI.Ly-I-2-NK-I+/ll Mediates ADCC.  Uncloned populations of cells that mediate 
certain types of ADCC copurify with NK cells (16,  17). We tested whether a cloned 
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FIG. 6.  ADCC with mouse  antibody. CI.Ly-t-2-NK-;+/11 was incubated with radiolabeled LPS- 
activated B 10.D2 B lymphocytes that had previously been incubated with the indicated antisera: 
A, none; ©, BALB anti-B6; e, B6 anti-BALB. 
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FIo.  7.  Conjugate formation of CI.Ly-I-2-NK-I+/ll with target cells. C1.Ly-I-2-NK-I+/ll was 
incubated with rhodamine dye, washed, and mixed with the indicated target cells. Suspensions were 
centrifuged, and cell pellets were resuspended and transferred immediately for counting. Data are 
expressed as the fraction of cloned ceils binding to no target cells, 1 target cell, 2-5 target cells, or 
>5 target cells. Cloned cells were distinguished  from target cells by the presence of intracellular 
rhodamine label. 
mediate ADCC. C1.Ly-1-2-NK-1+/11  cells were incubated in the presence of rabbit 
antibodies  to  mouse  lymphocytes  with  the  NK-resistant  mouse  leukemia,  RL-12. 
Addition of this antibody increased lysis at effector:target ratios of 1:1 or less. No lysis 
was observed after incubation with immunoglobulin directed against irrelevant target 
cells  (Fig.  5).  We  have  also  observed  ADCC  using  mouse  Ig.  Addition  of mouse 
alloantibodies directed against H-2  a targets, but not irrelevant antibodies, enhanced 
lytic activity against sensitive B 10.D2 LPS-activated B  cells (Fig. 6). 
Conjugate'Formation.  C1.Ly-I-2-NK-I+/11 was internally labelled with rhodamine 
dye, mixed (1:10) with target cells, and the mixtures were transferred immediately for 
counting by fluorescence microscopy. Cloned cells formed conjugates with sensitive 
(YAC-1, EL4,  LPS-activated B  cells), but not resistant  (RL-12)  target cells (Fig.  7). 
The  average  conjugate  size  was  1  effector/2-5  target  cells,  although  many  1:1 
conjugates were observed. 1588  LYMPHOCYTE CLONES 
Discussion 
Uncloned  NK cells lyse certain tumor and normal targets and bear characteristic 
surface membrane antigens. We now find that cloned populations that similarly lyse 
various  malignant  and  normal  cells  also  carry  the  cell  surface  molecular  labels 
attributed to activated NK cells. In particular, these cells display the NK-1 antigen, 
which has thus far been found only on NK cells. We do not know whether these cells 
are uniquely  responsible for activated NK cell function.  Data from uncloned  popu- 
lations suggests that several cell sets may contribute to NK activity (13-15,  30,  31). 
Activated  NK  cells  appear  after  stimulation  with  a  variety  of agents,  including 
partially  purified  IF or  agents  that  induce  IF secretion  (10,  12,  13).  Whether  this 
activity  reflects  the  differentiation  of  a  single  NK  cell  set  or  activation  of  an 
independent line of NK-related cells is unknown. Evidence from cold target inhibition 
studies  supports  the  notion  that  both  cell  types recognize similar  target  structures 
(31),  suggesting an  ontologic  relationship  between  these cells.  In this study,  CI.Ly- 
1-2-/NK-I+/11  has been  grown  in  media containing  IF  (A.  Neber, personal  com- 
munication)  and has properties displayed by activated NK cells. 
In  uncioned  populations,  the  definition  of NK activity  has  become increasingly 
obscure.  Lysis  of susceptible  NK  targets  such  as  the  YAC-1  lymphoma  has  been 
adopted as one measure of NK cell function.  But most cell populations also contain 
cytotoxic  T  lymphocytes  (CTL),  whose  activity  may  contribute  to  the  lysis  of 
lymphoma cells. These CTL, or their immediate precursors, also have been found in 
nude  mouse strains  (32).  Even when  antisera  and  complement are used  to deplete 
CTL,  single  treatments  may  not  be  sufficient  to  lyse  cells  that  bear  a  particular 
surface antigen (8). Therefore, we cannot completely exclude a contribution of T  cells 
or  macrophages  to  activated  NK  cell  function  in  vivo,  and  we  have occasionally 
observed Lyt-2  + clones in vitro that lyse the YAC-1 lymphoma. 
The  clone  described  here  differs  from  CTL  because  it  does  not  bear  the  Lyt-2 
glycoprotein by immunofluorescence and is resistant  to treatment with antisera and 
complement.  In  contrast  to  Lyt-2  +  cell  clones,  the  clone  described  here  does  not 
contain PAS-positive material. In addition, it does not show an H-2-restricted pattern 
of lysis, although we do not know whether H-2 molecules must be present for lysis to 
occur. We have also found that C1.Ly-1-2-NK-1+/11 is dependent on a factor similar 
to T  cell growth  factor for its proliferation  (data not  shown).  By these criteria,  the 
clone described in this report represents a  line of differentiation closely related to T 
cells.  Because CI.Ly- 1-2-NK- 1+/11  bears the Thy- 1 and Ly-5 glycoproteins, it may 
belong to early cells of the thymus-dependent  lineage;  however, these glycoproteins 
are not exclusively expressed on T  lymphocytes (33, 34). Unlike mature macrophages, 
this clone does not adhere to plastic, does not phagocytize antibody-coated erythro- 
cytes,  and  does  not  contain  the  nonspecific  esterase  enzyme.  Cells  contain  many 
vacuoles  and  large  eosinophilic  granules  (Fig.  2)  that  do  not  carry  peroxidase, 
lysozyme, or glycosylated material as determined by the  PAS reaction, but  they do 
contain the acid phosphatase enzyme. The presence of prominent lysosomal granules 
raises the possibility that lysosomal enzymes are involved in NK lysis. Although C1.Ly- 
1-2-NK-1+/11 cell lysates do not mediate YAC-1 lymphoma lysis (data not shown), 
additional  steps involving recognition of target structures  may be required  for their 
activation. 
In uncloned populations, the cells that perform NK function also express selective NABEL, BUCALO, ALLARD, WIGZELL, AND CANTOR  1589 
ADCC  activity (17), but whether the same population can perform both functions 
has not been shown. We now find that CI.Ly-I-2-NK-I+/11 can mediate at least two 
specialized functions. In addition to their ability to lyse certain malignant and normal 
cells, C1.Ly-I-2-NK- 1+/11 can mediate ADCC. In principle, the NK activity observed 
in  these  experiments  could  be  mediated  by  ADCC  because  FCS  contains  small 
quantities of Ig, which might bind to target cells and mimic NK activity. We cannot 
presently exclude this  possibility,  although  several  observations  do  not  support  it. 
First,  lysis did  not  vary according to the source of serum  used  in culture.  Second, 
addition  of antibody  to  NK-susceptible  target  cells  increased  lysis.  To  rigorously 
confirm that  CI.Ly-I-2-NK-I+/11  NK activity is due not to ADCC, however, cells 
must be grown in a defined medium in the absence of serum. 
We have also found that C1.Ly-I-2-NK-I+/11 can use mouse Ig to enhance lysis of 
target cells (Fig. 6). This finding, together with the observed lysis of syngeneic B cells, 
raises  the  possibility  that  this  cell  may be  involved in  the  regulation  of antibody 
secretion.  We  do  not  know  whether  lysis  of LPS-activated  B  lymphocytes occurs 
through an NK mechanism  or through ADCC.  LPS-activated B  lymphocytes may 
express  viral  determinants  (35,  36),  and  these  molecules may  serve as  NK  target 
structures. Alternatively, autoantibodies or anti-idiotypes synthesized by B lympho- 
cytes could be used  to direct  lysis via ADCC,  which  could lead  to specific clonal 
deletion. In either ease, the observation that cells of the NK type recognize and lyse 
activated B  lymphocytes suggests that  these cells may play an important role in Ig 
secretion. 
Despite evidence that our cloned populations are homogeneous, it is possible that 
cells  continuously  differentiate  into  subsets  in  cell  culture,  and  that  this  may be 
recognized in the future by antisera to immunogenetic markers not yet defined. We 
have observed similar  multiple  biologic activities  in  an  inducer T  cell clone  (37). 
Because we are not certain whether the cells of CI.Ly-I-2-NK-1 +/11 are uniform, the 
question whether individual cells can perform multiple biologic functions must await 
further investigation. 
Summary 
A  special class of immunologic cells can lyse or damage a  variety of target cells, 
notably malignant cells in vitro. These cells have been called natural killer (NK) cells 
because lysis does not require deliberate immunization by tumor cells. Although these 
cells can  be distinguished  from conventional T  cells,  B  cells, and  phagocytic cells, 
they have been difficult to define. 
We describe a  representative cloned cell line that was obtained by cloning Ig-Ly- 
5  + cells from spleen. This clone, CI.Ly-I-2-NK-I+/11, displays Thy-1, Ly-5, Qat-4, 
Qat-5, and NK-1 cell surface antigens, and lyses the NK-sensitive YAC-1 lymphoma 
cells, but does not lyse RL-12 cells, an NK-resistant lymphoma. In addition, this clone 
lysed  the  P815  mastocytoma, EL4 lymphoma,  and  lipopolysaccharide-activated B 
lymphocyte targets.  This  cloned  population  therefore combined  information  for a 
unique display of cell surface antigens and specialized function similar to "activated" 
NK cells. Because this cloned population forms conjugates with susceptible but not 
resistant  target  cells,  it  may  prove  useful  to  identify  the  structure  of cell  surface 
molecules that recognize foreign cells.  Finally, cells of this clone also specifically lysed 
target cells coated by antibodies to determinants on the target cell surface, demon- 1590  LYMPHOCYTE  CLONES 
strating that a single cloned cell population can mediate two specialized immunologic 
functions: antibody-dependent cellular cytotoxicity and NK cell lysis. 
Received  for publication 24 February 1981. 
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